NATALIE DRISCOLL: Open Payments
NPI 1982014502 · MIDDLETOWN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 49 payments from 13 companies in 2025. Trend: 2023 $919 · 2024 $945 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $262 |
| ABBVIE INC. | 14 | $231 |
| Galderma Laboratories, L.P. | 5 | $135 |
| LEO Pharma Inc. | 4 | $109 |
| Amgen Inc. | 1 | $86 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $55 |
| PFIZER INC. | 2 | $50 |
| GENZYME CORPORATION | 1 | $43 |
| Lilly USA, LLC | 2 | $32 |
| Janssen Biotech, Inc. | 1 | $28 |
Products named: COSENTYX, SKYRIZI, NEMLUVIO, ADBRY, OTEZLA, Cabtreo, RINVOQ, CIBINQO.
Industry payments across RI — which companies pay providers there.
